LanZhou Foci Pharmaceutical Co.,Ltd. (002644.SZ)
CNY 7.25
(-0.82%)
CNY 7.25
(-0.82%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 361.29 Million CNY | 26.23% |
| 2022 | 286.21 Million CNY | 28.26% |
| 2021 | 223.14 Million CNY | 34.92% |
| 2020 | 165.38 Million CNY | -1.08% |
| 2019 | 167.19 Million CNY | -4.38% |
| 2018 | 174.84 Million CNY | 17.31% |
| 2017 | 149.05 Million CNY | 37.71% |
| 2016 | 108.24 Million CNY | 30.95% |
| 2015 | 82.65 Million CNY | -6.46% |
| 2014 | 88.36 Million CNY | -14.93% |
| 2013 | 103.87 Million CNY | 19.55% |
| 2012 | 86.88 Million CNY | -6.77% |
| 2011 | 93.19 Million CNY | -1.82% |
| 2010 | 94.92 Million CNY | 7.82% |
| 2009 | 88.03 Million CNY | 0.96% |
| 2008 | 87.2 Million CNY | 20.06% |
| 2007 | 72.62 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 71 Million CNY | -16.77% |
| 2024 Q3 | 62.88 Million CNY | -11.43% |
| 2024 Q1 | 85.3 Million CNY | -24.27% |
| 2023 Q4 | 112.63 Million CNY | 96.31% |
| 2023 FY | 361.29 Million CNY | 26.23% |
| 2023 Q3 | 57.37 Million CNY | -47.52% |
| 2023 Q1 | 81.94 Million CNY | -5.16% |
| 2023 Q2 | 109.33 Million CNY | 33.42% |
| 2022 Q4 | 86.4 Million CNY | 68.52% |
| 2022 Q3 | 51.27 Million CNY | -34.63% |
| 2022 FY | 286.21 Million CNY | 28.26% |
| 2022 Q2 | 78.43 Million CNY | 11.89% |
| 2022 Q1 | 70.1 Million CNY | 171.29% |
| 2021 Q2 | 49.42 Million CNY | -8.14% |
| 2021 Q4 | 25.84 Million CNY | -72.53% |
| 2021 FY | 223.14 Million CNY | 34.92% |
| 2021 Q1 | 53.8 Million CNY | 120.63% |
| 2021 Q3 | 94.07 Million CNY | 90.32% |
| 2020 Q3 | 49.65 Million CNY | -8.1% |
| 2020 Q1 | 37.32 Million CNY | -0.12% |
| 2020 FY | 165.38 Million CNY | -1.08% |
| 2020 Q4 | 24.38 Million CNY | -50.88% |
| 2020 Q2 | 54.02 Million CNY | 44.77% |
| 2019 Q2 | 45.89 Million CNY | 26.61% |
| 2019 Q4 | 37.36 Million CNY | -21.62% |
| 2019 FY | 167.19 Million CNY | -4.38% |
| 2019 Q1 | 36.25 Million CNY | -14.32% |
| 2019 Q3 | 47.67 Million CNY | 3.87% |
| 2018 Q2 | 41.25 Million CNY | -4.22% |
| 2018 FY | 174.84 Million CNY | 17.31% |
| 2018 Q4 | 42.31 Million CNY | -12.24% |
| 2018 Q3 | 48.21 Million CNY | 16.87% |
| 2018 Q1 | 43.06 Million CNY | -22.26% |
| 2017 FY | 149.05 Million CNY | 37.71% |
| 2017 Q3 | 29.49 Million CNY | -11.92% |
| 2017 Q4 | 55.4 Million CNY | 87.81% |
| 2017 Q2 | 33.48 Million CNY | 9.22% |
| 2017 Q1 | 30.66 Million CNY | 7.95% |
| 2016 Q4 | 28.4 Million CNY | 6.62% |
| 2016 Q1 | 22.79 Million CNY | 44.23% |
| 2016 Q2 | 30.39 Million CNY | 33.33% |
| 2016 FY | 108.24 Million CNY | 30.95% |
| 2016 Q3 | 26.64 Million CNY | -12.35% |
| 2015 Q4 | 15.8 Million CNY | -35.08% |
| 2015 Q3 | 24.34 Million CNY | 5.46% |
| 2015 Q2 | 23.08 Million CNY | 18.92% |
| 2015 Q1 | 19.41 Million CNY | -8.12% |
| 2015 FY | 82.65 Million CNY | -6.46% |
| 2014 Q4 | 21.13 Million CNY | -17.94% |
| 2014 Q3 | 25.75 Million CNY | 17.77% |
| 2014 Q2 | 21.86 Million CNY | 11.44% |
| 2014 Q1 | 19.61 Million CNY | 28.46% |
| 2014 FY | 88.36 Million CNY | -14.93% |
| 2013 Q3 | 32.66 Million CNY | -1.98% |
| 2013 Q1 | 22.6 Million CNY | 15.83% |
| 2013 Q4 | 15.27 Million CNY | -53.25% |
| 2013 FY | 103.87 Million CNY | 19.55% |
| 2013 Q2 | 33.32 Million CNY | 47.45% |
| 2012 Q1 | 16.24 Million CNY | 62.56% |
| 2012 Q2 | 23.68 Million CNY | 45.81% |
| 2012 Q3 | 27.44 Million CNY | 15.86% |
| 2012 FY | 86.88 Million CNY | -6.77% |
| 2012 Q4 | 19.51 Million CNY | -28.89% |
| 2011 FY | 93.19 Million CNY | -1.82% |
| 2011 Q4 | 9.99 Million CNY | -73.45% |
| 2011 Q3 | 37.63 Million CNY | 70.67% |
| 2011 Q2 | 22.05 Million CNY | -6.22% |
| 2011 Q1 | 23.51 Million CNY | -7.44% |
| 2010 Q3 | 32.16 Million CNY | 0.0% |
| 2010 Q4 | 25.4 Million CNY | -21.03% |
| 2010 FY | 94.92 Million CNY | 7.82% |
| 2009 FY | 88.03 Million CNY | 0.96% |
| 2008 FY | 87.2 Million CNY | 20.06% |
| 2007 FY | 72.62 Million CNY | 0.0% |